NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Niowave Inc.

Niowave Inc.

Private
Lansing, MichiganHealthcare & Life Scienceshttps://niowaveinc.com/

Last Round

Strategic

Feb 11, 2026

Total Funding Raised

$15.75M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Niowave Inc. is a healthtech and manufacturing company that develops and operates superconducting electron linear accelerators for the production of medical radioisotopes used in cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Precision Medicine, Defense Tech, Biotech Equipment

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical radioisotopessuperconducting linear acceleratorActinium-225isotope manufacturinglinacradioligand therapyradiopharmaceuticalsreactor-free isotopesdomestic isotope supplypharma supply chainMolybdenum-99radiochemistry servicesisotope supply agreementsaccelerator technologyaccelerator components

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Niowave Inc. Comparables

Compare Niowave Inc. with similar companies based on industry and business-model similarity.

Niowave Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nusano
87%
NorthStar Medical Radioisotopes, LLC
86%
PanTera
82%

Niowave Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicFeb 11, 2026
GrantOct 14, 2025
GrantApr 11, 2023
VC RoundJan 21, 2022
GrantDec 3, 2021
Grant
Nov 20, 2013

Key People

Founding team and executive leadership

Terry Grimm

Founder & Chief Science Officer

Founding Team

Adam Havey

Chief Operating Officer

Executive Team

Jerry Hollister

Director Of Government Contracts Chief Operating Officer, Board Of Directors

Executive Team

Niowave Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2026

    Novartis led the strategic round.

  • Oct 14, 2025

    $751K grant from Michigan Strategic Fund

Niowave Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Niowave Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Niowave Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersLansing, Michigan
Employee Range186
Year Founded2005
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.